作者: Friedhelm Raue , Karin Frank-Raue , Andreas Grauer
DOI: 10.1016/S0889-8529(18)30121-X
关键词:
摘要: Prospective screening programs have changed the presenting clinical features of MEN 2, association medullary thyroid carcinoma, pheochromocytoma, and parathyroid disease. Currently, all manifestations 2 syndrome can be diagnosed at an early stage. Gene carrier status identified by characterization specific mutations. for carcinoma calcitonin testing pheochromocytoma several techniques routinely permits identification manifestations.